Nikki S IJzerman

5PUBLICATIONS
36CO-AUTHORS
Molecular targetsEpigenetics (incl. genome methylation and epigenomics)Cancer therapy (excl. chemotherapy and radiation therapy)Gene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Nov 02, 2021
Taste, smell and mouthfeel disturbances in patients with gastrointestinal stromal tumors treated with tyrosine-kinase inhibitors.

Jip M van Elst, Nikki S IJzerman, Ron H J Mathijssen

|Oct 07, 2021
Adjuvant Imatinib in Patients with GIST Harboring Exon 9 KIT Mutations: Results from a Multi-institutional European Retrospective Study.

Bruno Vincenzi, Andrea Napolitano, Marta Fiocco

|Jul 30, 2021
Location of Gastrointestinal Stromal Tumor (GIST) in the Stomach Predicts Tumor Mutation Profile and Drug Sensitivity.

Ashwyn K Sharma, Jorge de la Torre, Nikki S IJzerman

|Aug 19, 2020
Neoadjuvant Systemic Treatment of Primary Angiosarcoma.

Kimberley M Heinhuis, Nikki S IJzerman, Winette T A van der Graaf

Pageof 1